Healthy adults
Conditions
Interventions
Duration: 4 weeks Follow-up duration: 2 weeks Test material: "
Dose: Take five capsules, three times a day Administration: Take five capsules after each meal
Sponsors
ORTHOMEDICO, Inc.
1. Seishin-kai Medical Association Inc, Takara Medical Clinic. 2. Evaluation Center of Health and Nutrition Inc.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Healthy Japanese adults
Exclusion criteria
Exclusion criteria: 1. At least one previous medical history of malignant tumor, heart failure or myocardial infarction 2. Currently under the treatment for either cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension or other chronic diseases 3. Currently taking medicines and/or herbal medicines 4. Allergic to medicines or foods related to the test food of this trial 5. Pregnant, lactating, or planning to get pregnant during the trial period 6. Enrolled into other clinical trials within the last 3 months before agreeing to participate in this trial 7. Judged unsuitable for participating in this trial by physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Body measuring 2. Physical examination 3. Internal medicine examination 4. Blood test 5. Urinalysis 6. Subjective symptom *1 Perform examinations and tests at 0 week and at 2 and 4 weeks after the ingestion and at follow-up period 2 weeks | — |
Countries
Japan
Contacts
Public ContactNaoko SUZUKI
ORTHOMEDICO, Inc. R&D Department
Outcome results
None listed